Skip to main content

Table 1 Patient Demographics

From: Cholinergic Anti-Inflammatory Pathway Activity and High Mobility Group Box-1 (HMGB1) Serum Levels in Patients with Rheumatoid Arthritis

  RA Controls P value
M/F (n) 4/9 5/6 ns
Age (years) 52 (32–82) 38 (26–73) 0.05
Disease Duration (years) 13 - -
Rheumatoid-factor positive (%) 11(85%) - -
C-reactive protein (mg/L) 14.5 (0.2–5.9) 1 (0.4–2.9) P<0.01
Disease activity score-28 (mean ± SD) 4.5 ± 0.94
co-Morbidities:    
HTN 0 1 ns
Hypothyroidism 1 1 ns
SLE 1 0 ns
Medications:    
Corticosteroids 7 0 0.006
NSAIDS 2 0 ns
β-Blockers 2 0 ns
Calcium Channel Antagonists 0 1 ns
DMARDs 10 0 0.002
TNF receptor Blockers 7 0 0.005
  1. aData expressed as median values. Range is given in parentheses. DAS-28 score is expressed as mean ± SD.